FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016590082> ?p ?o ?g. }

• W2016590082 endingPage "164" @default.
• W2016590082 startingPage "157" @default.
• W2016590082 abstract "In the present study we have classified the receptor(s) mediating increases in intracellular calcium concentration ([Ca2+]i) in human washed platelets and compared the pharmacological profile obtained with that observed in Jurkat cells, stably transfected with a bovine P2Y1-receptor. The P2Y1-receptor antagonist, adenosine-3′-phosphate-5′-phosphate (A3P5P), competitively antagonized agonist responses in both Jurkat cells, and in platelets with similar affinities (pKB of 5.8 and 6.0, respectively). The selective P2YADP antagonist, AR-C66096, exhibited partial agonism in the Jurkat cells with an affinity (pKA) of 4.9. This value is consistent with its known P2Y1-receptor activity. In platelets, AR-C66096 at a concentration (0.1 μM) approximately 100 fold greater than its known P2YADP receptor affinity, had no effect on ADP-induced increases in [Ca2+]i. The ability of adenine nucleotide analogues to elevate [Ca2+]i in the Jurkat cells was also determined. The rank order of agonist potency (p[A]50) was: 2-MeSADP (8.3)>2-ClATP (7.8)>ADP (7.5)=2-MeSATP (7.4)>ATPγS (6.5)>ATP (6.2), with ATP appearing to be a partial agonist. The same rank order of potency was observed when similar experiments were performed in platelets. However, the absolute potencies of all the agonists and the intrinsic activities of both ATPγS and ATP were lower in platelets. The operational model of agonism was used to test whether the agonist concentration-effect profiles obtained in these two cell types could be explained on the basis of differences in receptor reserve. The analysis indicated that the data obtained in platelets closely resembled that predicted for a low density or poorly coupled P2Y1-receptor system. The hypothesis that the observed partial agonist behaviour of ATP was the result of receptor activation by contaminating ADP with concomitant receptor blockade by ATP, was tested in the platelet system. This hypothesis was supported by a theoretical analysis, which yielded an affinity value for ATP similar to that obtained previously at P2Y1-receptors. In summary, the results of this study indicate that human washed platelets contain P2Y1-receptors which mediate increases in [Ca2+]i and that this receptor population is pharmacologically distinct from P2YADP-receptors." @default.
• W2016590082 created "2016-06-24" @default.
• W2016590082 creator A5007017900 @default.
• W2016590082 creator A5010930800 @default.
• W2016590082 creator A5016092938 @default.
• W2016590082 creator A5059588814 @default.
• W2016590082 creator A5067532435 @default.
• W2016590082 creator A5070919635 @default.
• W2016590082 creator A5076330866 @default.
• W2016590082 creator A5084417962 @default.
• W2016590082 date "1998-05-01" @default.
• W2016590082 modified "2023-10-18" @default.
• W2016590082 title "P2Y₁ -receptors in human platelets which are pharmacologically distinct from P2Y_ADP -receptors" @default.
• W2016590082 cites W1657825487 @default.
• W2016590082 cites W1965132832 @default.
• W2016590082 cites W1973298520 @default.
• W2016590082 cites W2008054762 @default.
• W2016590082 cites W2009087137 @default.
• W2016590082 cites W2017450138 @default.
• W2016590082 cites W2017525398 @default.
• W2016590082 cites W2026178356 @default.
• W2016590082 cites W2040943961 @default.
• W2016590082 cites W2053278403 @default.
• W2016590082 cites W2056962336 @default.
• W2016590082 cites W2057348460 @default.
• W2016590082 cites W2057947793 @default.
• W2016590082 cites W2059703919 @default.
• W2016590082 cites W2069142911 @default.
• W2016590082 cites W2069222444 @default.
• W2016590082 cites W2073522296 @default.
• W2016590082 cites W2074762647 @default.
• W2016590082 cites W2075760418 @default.
• W2016590082 cites W2088438515 @default.
• W2016590082 cites W2089314265 @default.
• W2016590082 cites W209067059 @default.
• W2016590082 cites W2094376177 @default.
• W2016590082 cites W2300983753 @default.
• W2016590082 cites W2343239405 @default.
• W2016590082 cites W2095677220 @default.
• W2016590082 doi "https://doi.org/10.1038/sj.bjp.0701827" @default.
• W2016590082 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1565376" @default.
• W2016590082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9630355" @default.
• W2016590082 hasPublicationYear "1998" @default.
• W2016590082 type Work @default.
• W2016590082 sameAs 2016590082 @default.
• W2016590082 citedByCount "98" @default.
• W2016590082 countsByYear W20165900822013 @default.
• W2016590082 countsByYear W20165900822016 @default.
• W2016590082 countsByYear W20165900822018 @default.
• W2016590082 countsByYear W20165900822019 @default.
• W2016590082 countsByYear W20165900822021 @default.
• W2016590082 crossrefType "journal-article" @default.
• W2016590082 hasAuthorship W2016590082A5007017900 @default.
• W2016590082 hasAuthorship W2016590082A5010930800 @default.
• W2016590082 hasAuthorship W2016590082A5016092938 @default.
• W2016590082 hasAuthorship W2016590082A5059588814 @default.
• W2016590082 hasAuthorship W2016590082A5067532435 @default.
• W2016590082 hasAuthorship W2016590082A5070919635 @default.
• W2016590082 hasAuthorship W2016590082A5076330866 @default.
• W2016590082 hasAuthorship W2016590082A5084417962 @default.
• W2016590082 hasBestOaLocation W20165900821 @default.
• W2016590082 hasConcept C12554922 @default.
• W2016590082 hasConcept C160225129 @default.
• W2016590082 hasConcept C170493617 @default.
• W2016590082 hasConcept C179464577 @default.
• W2016590082 hasConcept C185592680 @default.
• W2016590082 hasConcept C203014093 @default.
• W2016590082 hasConcept C2776090121 @default.
• W2016590082 hasConcept C2776885963 @default.
• W2016590082 hasConcept C2777399203 @default.
• W2016590082 hasConcept C2778938600 @default.
• W2016590082 hasConcept C2993802102 @default.
• W2016590082 hasConcept C55493867 @default.
• W2016590082 hasConcept C86803240 @default.
• W2016590082 hasConcept C86811712 @default.
• W2016590082 hasConcept C8891405 @default.
• W2016590082 hasConcept C89560881 @default.
• W2016590082 hasConceptScore W2016590082C12554922 @default.
• W2016590082 hasConceptScore W2016590082C160225129 @default.
• W2016590082 hasConceptScore W2016590082C170493617 @default.
• W2016590082 hasConceptScore W2016590082C179464577 @default.
• W2016590082 hasConceptScore W2016590082C185592680 @default.
• W2016590082 hasConceptScore W2016590082C203014093 @default.
• W2016590082 hasConceptScore W2016590082C2776090121 @default.
• W2016590082 hasConceptScore W2016590082C2776885963 @default.
• W2016590082 hasConceptScore W2016590082C2777399203 @default.
• W2016590082 hasConceptScore W2016590082C2778938600 @default.
• W2016590082 hasConceptScore W2016590082C2993802102 @default.
• W2016590082 hasConceptScore W2016590082C55493867 @default.
• W2016590082 hasConceptScore W2016590082C86803240 @default.
• W2016590082 hasConceptScore W2016590082C86811712 @default.
• W2016590082 hasConceptScore W2016590082C8891405 @default.
• W2016590082 hasConceptScore W2016590082C89560881 @default.
• W2016590082 hasIssue "1" @default.
• W2016590082 hasLocation W20165900821 @default.
• W2016590082 hasLocation W20165900822 @default.
• W2016590082 hasLocation W20165900823 @default.
• W2016590082 hasLocation W20165900824 @default.

• next